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Abstract
This communication presents quantitative studies of the dynamic adhesion behavior of 
mesenchymal stem cells (MSCs) enabled by the combination of cell-surface receptor-ligand 
interactions and three-dimensional hydrodynamic control by microtopography.
Cell adhesion plays an essential role in many cellular processes, and many cell types exhibit 
focal adhesions on substrates such as the extracellular matrix. Corresponding micro-
patterning techniques have been developed for in-vitro control of cell adhesion, including 
that of MSCs.1,2 In contrast to these focal adhesions, some types of cells exhibit dynamic 
adhesion called cell rolling that is mediated by transient ligand-receptor interactions that 
form and break under the influence of hydrodynamic fluid shear.3 In particular, migration of 
circulating cells (i.e. leukocytes, tumor cells, and stem cells) from vascular to extravascular 
sites is initiated by these weak, transient interactions between carbohydrate ligands on the 
cells and selectin molecules (i.e. P- and E-selectin) on the vascular endothelium, which 
results in the characteristic rolling behavior followed by firm adhesion and 
transmigration.3-6 These interactions are also implicated in the homing of MSCs, which are 
self-renewing, multipotent cells that offer significant therapeutic potential due to their 
regenerative and immunomodulatory capacity, lack of ethical issues, and the ability to 
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transplant allogeneic MSCs without immunosuppressive therapy.7-9 According to the FDA 
clinical trial database, MSCs are being explored in more than 250 clinical trials worldwide10 
and a significant portion of these trials involve systemic infusion, where homing to diseased 
or damaged tissue is presumed to be important for maximizing therapeutic benefit.11-13 
However, while the adhesive interactions that mediate homing have been well described for 
leukocytes,3 the degree of adhesive interactions and the molecules involved remain unclear 
for MSCs.14-18 Since insufficient homing of systemically infused culture expanded MSCs is 
a significant obstacle for effective therapy,11-13 understanding the adhesion dynamics of 
MSCs is crucial not only for extending our knowledge of fundamental stem cell biology, but 
also for developing new approaches to enhance MSC homing.
Parallel-plate flow chambers coated with adhesion molecules or activated endothelial cells 
have been previously employed for in vitro rolling adhesion assays of MSCs14-18 as well as 
leukocytes,19 leukemic cell lines,20 cancer cell lines,21 CD34+ bone marrow cells,22 and 
CD34+ hematopoietic stem cells.23 This platform has contributed to advancing our 
understanding of the dynamics of cell rolling adhesion. However, a significant barrier to the 
quantitative implementation of this assay, especially for weakly interacting cells like 
MSCs,14,15 is the inability to initiate cell rolling (known as tethering) in the flow chambers 
and the difficulty in maintaining rolling interactions under dynamic flow conditions. Within 
the flow chambers, settling of cells prior to adhesion analysis can enhance adhesion, but this 
approach is non-physiological and typically insufficient in the case of weak and non-robust 
adhesive interactions where hydrodynamic lift forces in a channel with uniform cross-
section can push the cells away from the surface.24,25 Microfluidic devices have recently 
employed mixing approaches using surface grooves to create circulating streamlines that 
enhance cell-surface interactions,26 resulting in higher cell capture efficiencies.27,28 These 
approaches, however, are inadequate for characterizing adhesion dynamics at the single cell 
level because cell capture is distributed along the length of the channels and only a biased 
fraction of the cell population that exhibits stronger adhesive interactions can be 
interrogated. Current approaches are, thus, not suitable to quantitatively examine weakly 
interacting MSCs. For understanding the adhesion dynamics of MSCs, efficient methods to 
promote adhesion interactions in dynamic flow and enable quantitative analysis of the 
rolling phenotype need to be developed.
Herein, we report a cell rolling cytometer (CRC) for forced tethering and directed 
transporting of cells in suspension using a three-dimensional microtopography coated with 
adhesion molecules, which enables quantification of cell-surface adhesion dynamics via 
transit time and lateral position at the single cell level (Figure 1). The device operation is 
based on “deterministic cell rolling”29,30 wherein three-dimensional adhesion ridges (AR) 
create rotational flow patterns and induce effective contact or tethering (i.e. initialization of 
molecular interactions) of cells with surfaces functionalized with adhesion molecules that 
support cell rolling. The device comprises a narrow focusing channel where the high shear 
stress prevents cell rolling, even though all channel surfaces are functionalized with 
adhesion molecules. The focusing channel is followed by a sudden increase in the channel 
width that lowers the level of shear stress and forces each incoming cell to interact with the 
AR. The AR focus non-interacting cells to one side of the device, and slow down and 
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laterally displace the trajectories of interacting cells (including those that typically display 
weak interactions) into the adjacent gutter region. The adhesion channel is designed with 
small dimensions (w × l = 200 μm × 2,000 μm) to fit within a microscope field of view, 
which enables observation and characterization of the adhesive interactions of every cell 
flowing through the channel. While we have previously used this effect to alter rolling 
trajectories for cell separation,29 the CRC is specifically designed to examine the adhesion 
characteristics of every cell in a given cell sample at the single cell level.
As a model system, we first tested a leukemic cell line, HL60, that expresses high levels of 
P-selectin glycoprotein ligand-1 (PSGL-1, CD62P) (Figure S2) and exhibits rolling on P-
selectin, mediated primarily by PSGL-1.31 The cells were introduced into the CRC 
functionalized with P-selectin at an incubation concentration (cs) of 1.5 μg/mL or passivated 
with 1% BSA as a negative control. The trajectories of HL60 cells that were subjected to a 
wall shear stress of 3.5 dyn/cm2 are shown in Figure 2. This nominal shear stress (τ) denotes 
the minimum shear stress on the top surfaces of the AR where cells can contact and tether. 
The shear stress was determined by computational fluid dynamics simulation (Fig. 2a, 
bottom) based on the flow rate set by the syringe pump. In the absence of adhesion 
interactions (BSA control), the physical interactions between the cells and the ridges force 
the cells to remain above the ridges where the flow converges toward the focusing side of 
the channel (Figure 2a and S3, top).29,30,32 Transient ligand-receptor interactions occur 
when the surfaces are coated with P-selectin, which mediates cell rolling along the AR, until 
they are detached in the gutter region (Figure 2a). In this case, the cell trajectories follow 
similar paths as the streamlines inside the trenches. This clearly indicates that the flow 
circulation not only enhances cell-surface interactions by inducing repeated collisions with 
the ridges, but also directs the flow of cells differently according to their affinity to adhesion 
ligands (Figure 1 and 2a). Transit-time and position measurements are represented in scatter 
plots (Figure 2b). The scatter plot was divided into quadrants such that nearly all of the cells 
in the control experiment with passivated channels were in the lower left quadrant. With this 
division, non-interacting cells were in the left lower quadrant and rolling, interacting cells 
were mostly in the right upper quadrant (Figures 2b and S4). The left upper quadrant 
indicates weakly interacting cells that can tether to the surface and undergo lateral 
displacement towards the gutter region, but are readily detached from the surface and 
therefore flow through quickly. The right lower quadrant represents a few interacting cells 
that undergo lateral displacement, but go back to the focusing side following the rotational 
flow (Figure 1). With the CRC, we observed that the adhesion interactions in the P-selectin-
coated channel slowed down HL60 cells (88.3% of the total incoming cells) to a velocity of 
7.4 ± 3.5 μm/s (n = 39) and prolonged their transit time to transverse the adhesion channel, 
compared to the BSA control where the cells were flowing fast at 1.5 ± 0.6 mm/s (n = 19) 
(Figure 2). Since the cells rolled only for a fraction of the distance in the adhesion channel in 
the P-selectin-coated device, they required ~35 s to traverse the adhesion channel compared 
to ~1.5 s for the BSA control (Figure 2b). Transit time can be a gauge to determine whether 
a cell interacts with adhesion molecules exhibiting a rolling response, while lateral position 
can be a gauge to determine the potential sorting efficiency29 of the rolling phenotype.
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Next, we examined how the shear stress affects the cell adhesion efficiency of the CRC, and 
compared it with that of a conventional flat flow chamber (w × h = 1,000 μm × 98 μm). We 
define the cell adhesion efficiency as the fraction of cells in the right two quadrants, i.e. cells 
that slow down and exhibit a rolling response, but that are not necessarily displaced to the 
gutter side. In the flat chamber, cells were allowed to settle on the bottom surface, and were 
then subjected to a shear stress corresponding to the minimum shear stress that cells can 
experience during tethering (i.e. initialization of molecular interactions on the top surfaces 
of the AR) in the CRC with spatial shear stress gradients (Figure 2a). All the devices for 
experiments with HL60 cells were functionalized with P-selectin at cs = 1.5 μg/mL. At a 
shear stress of 3.5 dyn/cm2, 86.9 ± 2.8% of cells in the CRC were in the right two quadrants 
(n = 3). At shear stresses of 7.7 and 10.5 dyn/cm2, the adhesion efficiency of the flat 
chamber was significantly compromised, with only ~26% of the cells exhibiting a rolling 
response at 10.5 dyn/cm2 while the remaining cells were washed away (Figure 2c). In 
contrast, the CRC exhibited high efficiency in capturing cells and supporting stable rolling 
in the range of shear stress (3.5 to 10.5 dyn/cm2). With increasing shear stress from 3.5 
dyn/cm2 to 7.7 dyn/cm2, the location where cells initiate rolling shifted to the seventh ridge 
where the level of shear stress is ~1.5 times lower than that at the first ridge, although there 
was no significant difference in cell-capture efficiency (Figures 2c and 2d). Since the level 
of shear stress and the number of ligand-receptor bonds affect the cell's ability to initiate and 
sustain rolling, the tethering profile and the fraction of interacting cells in the CRC is 
consequently modulated, reflecting the diminished ability of cells to tether at higher shear 
stresses. The results demonstrate that compared to a flat flow chamber, the CRC can more 
readily achieve sufficiently high cell adhesion efficiency for quantitative analysis of cell 
adhesion. Under an optimal condition, most of the cells capable of a rolling response were 
observed to roll in the adhesion channel (~86.9% of HL60 cells), indicating that the CRC is 
capable of interrogating the rolling behavior of almost every cell that flows through the 
device.
After characterization of the CRC with HL60 cells, we performed cell adhesion cytometry 
on human MSCs derived from human bone marrow (Lonza, Walkersville, MD) to examine 
their adhesion phenotype. Since it has been suggested that human MSCs exhibit a rolling 
response on activated endothelial cells,14 we first examined adhesion to E- and P-selectin 
which are expressed on the surface of activated endothelium and mediate rolling of 
circulating cells.3 The CRC was functionalized with P- or E-selectin at a concentration cs = 
30 μg/mL. Following each MSC experiment, the surface functionalization of the adhesive 
channel with P- or E-selectin was verified using HL60 cells that interact with both selectins1 
as positive control. As shown in Figures 3 and S5, the majority of MSCs (85.3 ± 4.0%, n = 
3) exhibited a rolling response (i.e., were in the right two quadrants) on E-selectin at τ = 1.7 
dyn/cm2 and cs = 30 μg/mL. The rolling response decreased with increasing shear stress, and 
increased with cs (Figures 3b and S5). An optimal condition τ = 1.7 dyn/cm2 and cs = 30 
μg/mL was used for subsequent rolling assays, unless otherwise specified. For comparison, 
the flat chamber was also functionalized with E-selectin at the same concentration cs = 30 
μg/mL. As expected, the CRC was highly effective at capturing cells, whereas significantly 
fewer cells were captured with the flat device (p < 0.01 using two-tailed unpaired t-test for 
all shear stress conditions tested), suggesting that forced cell tethering is crucial for initiation 
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of rolling adhesion. There were no observable adhesion events in P-selectin-coated channels 
(Figure 3a). Our results suggest that MSCs exhibit specific transient adhesion on E-selectin-
coated surfaces.
This result is especially significant given that inflammatory cytokines such as tumor 
necrosis factor-α up-regulate the expression of E-selectin, but not of P-selectin, in human 
endothelial cells.33,34 The stronger adhesion to E-selectin observed here suggests that E-
selectin may play a major role in recruitment of MSCs in humans and its precise role in vivo 
warrants further investigation. It is noteworthy that MSCs have been previously shown to 
exhibit poor rolling properties on selectin-coated flat surfaces.14,17 The increased rolling 
response in this study likely resulted from synergy between forced cell contact by rotational 
flow control which can facilitate tethering and rolling and the high concentration of selectins 
(30 μg/mL), compared with the low concentration of selectins (5–10 μg/mL) and weak 
contact by gravitational settling in previous studies.17 Given the difficulty of studying MSC 
adhesion in flat flow chambers, the CRC is an effective tool to probe the rolling adhesion of 
a cell type that exhibits weak, non-robust rolling properties.
Next, we examined the effect of removal of cell surface residues that are known to be 
associated with rolling adhesion on the rolling response of MSCs. The binding receptors of 
MSC adhesion still remain unknown,35,36 although one study suggests that human MSCs 
exhibit weak rolling on human umbilical cord vein endothelial cells mediated by P-selectin 
and VCAM-1.14 As determined by flow cytometry, MSCs lacked E-selectin ligands such as 
CD15s, CD18, CD24, CD43, CD65, and CD162 (Figure S6a). We therefore used the CRC 
to test the susceptibility of the unknown binding receptors on MSCs for E-selectin to 
treatment with O-sialoglycoprotein endopeptidase (O-glycoprotease) or neuraminidase. 
Neuraminidase and O-glycoprotease are enzymes that cleave neuraminic acids (including O- 
and N-substituted derivatives called sialic acids) and O-linked sialoglycoproteins that 
support selectin-mediated rolling, respectively.37,38 The CRC was functionalized with E-
selectin at cs = 30 μg/mL. The shear stress was adjusted between 1.1 dyn/cm2 and 1.7 
dyn/cm2 to achieve sufficiently high rolling response (73.0 ± 7.2%) for the untreated control 
MSCs. The ability of MSCs to form rolling adhesion was significantly blocked by treatment 
with neuraminidase, while treatment with O-glycoprotease failed to inhibit the rolling 
response (Figure 3c). Interestingly, flow cytometry revealed that the enzymes cleave the E-
selectin ligands CD15s and CD43, respectively, on HL60 cells (Figure S8). The results 
implicate sialic acid residues in MSC rolling on E-selectin.
Finally, we examined the ability of the CRC to detect alterations in the rolling phenotype of 
MSCs (Figure 4). Given that MSCs undergo dramatic phenotypic changes in morphology 
and cell-surface adhesive interactions during differentiation,39,40 we tested the hypothesis 
whether the rolling adhesion phenotype of MSCs correlates with their differentiation state. 
For induction of differentiation into adipocytes or osteoblasts, the medium was replaced 
with either an adipogenic differentiation medium or the MSC culture medium supplemented 
with 10 nM dexamethasone,41 respectively. The cells were harvested on day 14 after 
induction of adipogenic and osteogenic differentiation, and the differentiation was 
confirmed by histochemical staining. Adipocytes differentiated from MSCs stained positive 
for Oil-Red-O and osteogenic cells differentiated from MSCs were positive for alkaline 
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phosphatase (Figure 4b). Analysis showed that the rolling response in both differentiated 
populations was significantly decreased relative to non-induced MSC control group, 
supporting the hypothesis that MSC differentiation leads to a quantifiable change in the 
adhesion phenotype (Figure 4a and S7). This decrease in cell rolling adhesion upon 
differentiation is not unexpected, as cell rolling is involved in trafficking of cells and we 
speculate that it may not be biologically useful once the MSCs are differentiated. To verify 
that differentiated cells lose their homing ability via adhesive interactions, we examined 
whether human adipocytes – obtained from adipogenic differentiation of primary human 
preadipocytes (Figure 4c)42,43 – and primary human osteoblasts44 exhibit cell rolling. As 
shown in Figure 4a and S9, both adipocytes differentiated from PACs and osteoblasts 
exhibited weak rolling response of 12.0 ± 6.3% and 25.3 ± 6.4%, respectively (n = 3, Figure 
4a), indicating that these cells do not exhibit robust cell rolling. Interestingly, PACs 
exhibited a rolling response (76.7 ± 15.8%, n = 3) similar to MSCs (Figure 4a and S9), 
showing that rolling appears to be lost at terminal differentiation, but more work is required 
to identify the specific point in the differentiation process where this transition occurs. The 
results demonstrate that the CRC is able to detect a statistically significant decrease in the 
rolling adhesion of MSCs upon differentiation that is consistent with the adhesion behavior 
of the corresponding mature cell types.
The quantitative analysis of transient cell-surface molecular interactions is limited by poor 
tethering efficiency of cells in conventional parallel-plate chambers.17,24 Forced cell 
tethering and directed rolling in the CRC can promote a robust rolling response even in 
dynamic flow and enable observation of adhesion events at the single cell level. The absence 
of significant tethering and rolling upon sedimentation on a flat surface suggests that the 
forced cell-surface contact by 3D streamline manipulation was critical to initiate MSC 
tethering and rolling in the CRC. The CRC also allowed the rolling response to be examined 
in a continuous flow as opposed to the batch analysis in conventional flow chambers. More 
significantly, the results demonstrate that enhancing the rolling response is critical to probe 
the adhesion of MSCs that exhibit relatively weak, non-robust rolling properties. The CRC 
enabled quantification of MSC rolling interactions and provided insight into the transient 
adhesion process of human MSCs, revealing that 1) E-selectin is an adhesion molecule that 
supports rolling adhesion of human MSCs, 2) the rolling response is mediated by sialic acid 
residues on MSCs, 3) a significant, quantifiable loss of rolling response occurs upon 
differentiation of MSCs, and 4) compared to leukocytes, MSCs may require greater contact 
force against the vascular endothelium to initiate tethering and rolling response in vivo. The 
loss of rolling ability upon differentiation suggests that differentiated MSCs may lose their 
homing ability in vivo. Importantly, the CRC was used to quantify changes in the rolling 
phenotype arising from weak adhesions in the absence of known ligands, where analysis by 
flow cytometry is not possible. The CRC is a potential quantitative tool for detecting 
changes in MSC phenotype, which could be useful for ensuring MSC quality control that is 
critical for cell-based therapy.
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Fig. 1. 
Cell rolling cytometer. (Top) Schematic of the microfluidic cell rolling cytometer (CRC), in 
which cells are forced into contact with adhesion molecule-coated ridges. Adhesion of single 
cells is quantified via transit time, tt, and rolling trajectory, xr. The red arrow indicates a 
schematic helical streamline. (Bottom) Cross-section views of the CRC. Without specific 
interactions a cell quickly travels through the channel, following the focusing trajectory. 
Specific adhesion interactions retard the cell and change its trajectory.
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Fig. 2. 
Characterization of the CRC using HL60 cells that exhibit robust rolling on P-selectin. a) 
Examples of trajectories of HL60 cells in (Top) BSA-passivated and (Middle) P-selectin-
coated channels. Each circle represents the position of a cell and is colored by the magnitude 
of its velocity. (Bottom) Simulation of the wall shear stress on the channel surfaces. Scale 
bar, 100 μm. b) Scatter plots of the transit time and lateral position of 394 cells in (Left) 
BSA-passivated and (Right) P-selectin-coated channels. c) Cell adhesion efficiency of HL60 
cells in the CRC (n = 4) compared to a control device with a flat chamber (n = 3) at the same 
shear stress where cells were first allowed to settle. Adhesion efficiency is defined as the 
fraction of cells that exhibit a rolling response, i.e. are in the right two quadrants. d) 
Tethering frequency of HL60 cells on each ridge (n = 4), calculated as the number of cells 
tethering at each ridge divided by the total number of rolling cells. Error bars show one 
standard deviation.
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Fig. 3. 
Quantification of the dynamic adhesion phenotype of MSCs. a) Scatter plots of the transit 
time and lateral position of 400 MSCs in (Left) IgG-passivated, (Middle) P-selectin-coated, 
and (Right) E-selectin-coated CRCs. b) Efficiency of MSC adhesion in the E-selectin-coated 
CRC (n = 4) and flat flow chamber (n = 3). c) Effects of enzyme treatments on MSC rolling 
adhesion (n = 3). The adhesion responses of enzyme-treated MSCs were normalized to 
untreated control cells. Significant difference in the rolling response between control and 
enzyme-treated MSCs was observed for neuraminidase (*, p < 0.001 using two-tailed 
unpaired t-test) but not O-glycoprotease (p = 0.24 using two-tailed unpaired t-test). NS 
denotes no significant difference. Error bars indicate one standard deviation.
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Fig. 4. 
Effect of differentiation on the dynamic adhesion phenotype of MSCs. a) The rolling 
response of MSCs decreased after induction of adipogenic and osteogenic differentiation. 
The corresponding mature cell types (adipocytes differentiated from primary human human 
preadipocytes (PACs) and primary human osteoblasts) exhibited weak rolling responses. *, 
p < 0.001 using one-way ANOVA followed by Tukey's post hoc test; the results for the cells 
differentiated from MSCs, adipocytes differentiated from PACs, and osteoblasts (n = 3) are 
significantly different from the results for undifferentiated MSC control (n = 4). No 
statistically significant differences were observed between the cells differentiated from 
MSCs, adipocytes differentiated from PACs, and osteoblasts (p > 0.05 using one-way 
ANOVA followed by Tukey's post hoc test). Error bars show one standard deviation. NS 
denotes no significant difference. b) Histochemical staining was performed to assess 
adipogenic (Upper, Oil Red O stain) and osteogenic (Lower, alkaline phosphatase stain) 
differentiation of MSCs. c) (Left) MSCs were derived from human bone marrow and their 
differentiated progeny were obtained by in vitro differentiation. Human primary osteoblasts 
were derived from human bone tissues. (Right) Adipocytes were obtained from in vitro 
differentiation of human primary PACs isolated from subcutaneous fat tissue.
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